• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Epistem Holdings plc

Epistem is a biotechnology company commercialising its expertise in epithelial stem cells in the areas of oncology, gastrointestinal and dermatological diseases. Epistem develops innovative therapeutics, biomarkers and diagnostics alongside providing contract research services to drug development companies. The Group's core expertise is focused on the regulation of adult stem cells located in epithelial tissue, which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. *

 

	Start	2000-01-01 established_pre
	Group	Epistem (Group)
	Industry	stem cell research
	Industry 2	BIOTECH
	Person	Walls, Matthew (EpiStem 200704 CEO)
	Person 2	Rylands, John (Epistem 201312 Finance Director)
	Region	Manchester, Greater Manchester
	Country	United Kingdom (GB)
	Street	48 Grafton Street
	City	M13 9XX Manchester
	Tel	+44-161-606-7258
		Address record changed: 2018-07-24
Basic data	Employees	n. a.
		* Document for �About Section�: OctoPlus N.V.. (5/20/11). "Press Release: Shareholders OctoPlus Appoint Jan Egberts to Executive Board". Leiden.
		Record changed: 2017-04-01

Advertisement

More documents for Epistem (Group)

• [1] Genedrive plc. (5/14/18). "Press Release: Proposed Disposal of the Company's Contract Research and Pharmacogenomics Divisions for up to £1.9 Million in Cash"....
• [2] Epistem Holdings plc. (2/19/16). "Press Release: Update on CEO Appointment"....
• [3] Epistem Holdings plc. (4/7/14). "Press Release: Epistem Announces Installation of UKs First Bruker Xtreme Imaging System"....
• [4] Epistem Holdings plc. (1/27/14). "Press Release: Epistem Announces Executive Board Appointment and the Strengthening of Its Personalised Medicine Diagnostics Senior Management Team"....
• [5] Epistem Holdings plc. (12/18/13). "Press Release: Epistem Announces Evaluation of Genedrive by US Department of Defence for Pathogen Detection"....
• [6] Epistem plc. (8/8/13). "Press Release: Epistem Receives a Prestigious FP7 Grant Award for the Development of Point of Care Hepatitis C Assays". Manchester....
• [7] Epistem Holdings plc. (3/5/12). "Press Release: Epistem Signs Tuberculosis Channel Partner Agreement"....
• [8] Epistem plc. (6/28/11). "Press Release: Tuberculosis Diagnostic Collaboration"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.